Table 2.

Summary of studies of blood doping and exercise

Authors	Date	Storage technique	Volume infuseda (ml)	Time of reinfusion post phlebotomy	Hb or Hct vs controlb (%)	$\dot{\text{V}}$O2max vs control (%)	End capacityc vs controlb (%)
Pace et al	1947	Freshg	2000	–	+26d	N.R	+34.7d
Gullbring et al	1960	Refridg	610	7 days	+0.7	N.R	+3
Robinson et al	1966	Refridg	1000	2 weeks	+4.8	+1.4	N.R
Ekblom et al	1972	Refridg	800	4 weeks	+2.1	+5.5e	+ 15.6e
		Refridg	1200	4 weeks	+1.3	+1.6e	+ 25.1e
Von Rost et al	1975	Refridg	900	3 weeks	+2.7	+9.0e	+ 375
Bell et al	1976	Refridg	500	3 weeks	+1.0	+5.6f	+ 7.5
Ekblom et al	1976	Refridg	800	~5 weeks	+4.5e	+8.0d	N.R
Videman and RytÖmaa	1977	Refridg	4–600	2–3 weeks	+2.6	N.R	+ 3.8
Robertson et al	1978 Abst	N.R	1800	NR	N.R.	+12.8d	+ 15.6d
Williams et al	1978	Frozen	460	3 weeks	+3.3	N.R	+ 4.1
Cottrell	1979 Abst	Frozen	405	9 weeks	N.R.	~+2.0f	N.R
Roberston et al	1979 Abst	N.R	800	N.R.	+15.8d	+30.5d	+ 13.1d
Buick et al	1980	Frozen	900	7 weeks	+11d	+5d	+ 35d
Spriet et al	1980 Abst	Frozen	800	11 weeks	+7.9d	+3.9d	N.R
			1200	12 weeks	+10.7d	+6.6d	N.R
Williams et al	1981	Frozen	920	7 weeks	+7d	N.R	+2.5d

Reproduced with permission from Wolters Kluwer Health [44]

NR data not reported, Refridg refrigerated

^aWhole blood or equivalent whole blood

^b Control pre-phlebotomy measurement

^cEndurance exercise capacity, physical work capacity or performance time

^dStatistically significant (P ≤ 0.05)

^eNo statistical analysis reported

^fPredicted from submaximal exercise heart rate

^gFresh homologous blood; all other studies used autologous blood